Cancer immune evasion through loss of MHC class I antigen presentation

K Dhatchinamoorthy, JD Colbert, KL Rock - Frontiers in immunology, 2021 - frontiersin.org
Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell's
expressed genes and then transport and display this antigenic information on the cell …

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo - Molecular cancer, 2021 - Springer
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy

Y Lu, YT Chan, HY Tan, S Li, N Wang, Y Feng - Molecular cancer, 2020 - Springer
Epigenetics is dynamic and heritable modifications to the genome that occur independently
of DNA sequence. It requires interactions cohesively with various enzymes and other …

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer

KGK Deepak, R Vempati, GP Nagaraju… - Pharmacological …, 2020 - Elsevier
Triple negative breast cancer (TNBC) is most aggressive subtype of breast cancers with high
probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC …

Immune checkpoints in the tumor microenvironment

SM Toor, VS Nair, J Decock, E Elkord - Seminars in cancer biology, 2020 - Elsevier
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy

S Kandel, P Adhikary, G Li, K Cheng - Cancer letters, 2021 - Elsevier
Immune checkpoint blockade has shown unprecedented and durable clinical response in a
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …

Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy

I Arora, M Sharma, TO Tollefsbol - International journal of molecular …, 2019 - mdpi.com
Polyphenols are potent micronutrients that can be found in large quantities in various food
sources and spices. These compounds, also known as phenolics due to their phenolic …

[HTML][HTML] Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses

X Chen, X Pan, W Zhang, H Guo, S Cheng, Q He… - … Pharmaceutica Sinica B, 2020 - Elsevier
Immunotherapy strategies targeting the programmed cell death ligand 1 (PD-
L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved …

PD-L1 status in breast cancer: current view and perspectives

S Vranic, FS Cyprian, Z Gatalica, J Palazzo - Seminars in cancer biology, 2021 - Elsevier
Breast cancer was traditionally not considered a particularly immunogenic tumor. However,
recent developments have shown that some aggressive triple-negative breast cancers are …

[HTML][HTML] Role of epigenetic modifications in inhibitory immune checkpoints in cancer development and progression

R Saleh, SM Toor, V Sasidharan Nair… - Frontiers in …, 2020 - frontiersin.org
A balance between co-inhibitory and co-stimulatory signals in the tumor microenvironment
(TME) is critical to suppress tumor development and progression, primarily via maintaining …